Targeting Candida spp. to develop antifungal agents

被引：25
|
作者：
Salci, Tania P. [1 ,2 ]
Negri, Melyssa [1 ]
Abadio, Ana K. R. [3 ]
Svidzinski, Terezinha I. E. [1 ]
Kioshima, Erika S. [1 ]
机构：
[1] Univ Estadual Maringa, Av Colombo 5-790 Jd Univ, BR-87020900 Maringa, Parana, Brazil
[2] Ctr Univ Integrado, Rodovia BR 158,Km 207, BR-87300970 Campo Mourao, Parana, Brazil
[3] Univ Estado Mato Grosso, Campus Nova Xavantina, BR-78690000 Nova Xavantina, Mato Grosso, Brazil
来源：
DRUG DISCOVERY TODAY | 2018年 / 23卷 / 04期
关键词：
RESPONSE REGULATOR GENE; CHITIN SYNTHASE GENE; PHOSPHOLIPASE-B GENE; MDR1 EFFLUX PUMP; REDUCED ECHINOCANDIN SUSCEPTIBILITY; MAJOR FACILITATOR SUPERFAMILY; AZOLE RESISTANCE MECHANISMS; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE;
D O I：
10.1016/j.drudis.2018.01.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Invasive fungal infections are a complex challenge throughout the world because of their high incidence, mainly in critically ill patients, and high mortality rates. The antifungal agents currently available are limited; thus, there is a need for the rapid development of new drugs. In silico methods are a modern strategy to explore interactions between new compounds and specific fungal targets, but they depend on precise genetic information. Here, we discuss the main Candida spp. target genes, including information about null mutants, virulence, cytolocalization, co-regulatory genes, and compounds that are related to protein expression. These data will provide a basis for the future in silico development of antifungal drugs.
引用
收藏
页码：802 / 814
页数：13
相关论文
共 50 条
  • [1] Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp.
    Ferreira, Thais Lima
    Leitao, Amanda Cavalcante
    da Silva, Lisandra Juvencio
    Sa, Livia Gurgel do Amaral Valente
    Cabral, Vitoria Pessoa de Farias
    Rodrigues, Daniel Sampaio
    Barbosa, Sarah Alves
    Neto, Joao Batista de Andrade
    Barbosa, Amanda Dias
    Moreira, Lara Elloyse Almeida
    Rios, Maria Erivanda Franca
    Cavalcanti, Bruno Coelho
    de Moraes, Manoel Odorico
    Nobre Junior, Helio Vitoriano
    da Silva, Cecilia Rocha
    FUTURE MICROBIOLOGY, 2024, 19 (13) : 1157 - 1170
  • [2] Antifungal Activity of Olive Oil and Ozonated Olive Oil Against Candida Spp. and Saprochaete Spp.
    Varol, Kemal
    Koc, Ayse Nedret
    Atalay, Mustafa Altay
    Keles, Ihsan
    OZONE-SCIENCE & ENGINEERING, 2017, 39 (06) : 462 - 470
  • [3] Aspartic proteinases of Candida spp.: role in pathogenicity and antifungal resistance
    Silva, Naiara C.
    Nery, Jessica M.
    Dias, Amanda L. T.
    MYCOSES, 2014, 57 (01) : 1 - 11
  • [4] Combined antibiofilm activity of synthetic peptides and antifungal drugs against Candida spp.
    Bezerra, Leandro P.
    Silva, Ayrles F. B.
    Santos-Oliveira, Ralph
    Alencar, Luciana M. R.
    Amaral, Jackson L.
    Neto, Nilton A. S.
    Silva, Rafael G. G.
    Belem, Monica O.
    de Andrade, Claudia R.
    Oliveira, Jose T. A.
    Freitas, Cleverson D. T.
    Souza, Pedro F. N.
    FUTURE MICROBIOLOGY, 2022, : 1133 - 1146
  • [5] Mechanisms of Developing Antifungal Drug Resistance of Candida spp. in Reccurent Urogenital Candidiasis
    Bezhenar, M. B.
    Plakhova, K. I.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2020, 35 (01) : 14 - 21
  • [6] In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp.
    Pippi, B.
    Lana, A. J. D.
    Moraes, R. C.
    Gueez, C. M.
    Machado, M.
    de Oliveira, L. F. S.
    Lino von Poser, G.
    Fuentefria, A. M.
    JOURNAL OF APPLIED MICROBIOLOGY, 2015, 118 (04) : 839 - 850
  • [7] Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp.
    Kocendova, Jitka
    Vankova, Eva
    Volejnikova, Andrea
    Nesuta, Ondrej
    Budesinsky, Milos
    Socha, Ondrej
    Hajek, Miroslav
    Hadravova, Romana
    Cerovsky, Vaclav
    FEMS YEAST RESEARCH, 2019, 19 (03)
  • [8] Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima, Franqueline
    Busso-Lopes, Ariane F.
    Lyra, Luzia
    Peron, Isabela Haddad
    Taguchi, Hideaki
    Mikami, Yuzuru
    Kamei, Katsuiko
    Moretti, Maria Luiza
    Schreiber, Angelica Z.
    MYCOSES, 2016, 59 (09) : 585 - 593
  • [9] Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
    Fekkar, A.
    Dannaoui, E.
    Meyer, I.
    Imbert, S.
    Brossas, J. Y.
    Uzunov, M.
    Mellon, G.
    Nguyen, S.
    Guiller, E.
    Caumes, E.
    Leblond, V.
    Mazier, D.
    Fievet, M. H.
    Datry, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (09) : 1489 - 1496
  • [10] Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil
    Spina Canela, Heliara Maria
    Cardoso, Barbara
    Vitali, Lucia Helena
    Coelho, Harnoldo Colares
    Martinez, Roberto
    Ferreira, Marcia Eliana da Silva
    MYCOSES, 2018, 61 (01) : 11 - 21
12345